Open
一種針對細菌復發性感染的新型治療平台。我們的產品抗體-抗生素偶聯藥物的特點是可以將兩種不同的藥物與抗體結合，為細菌耐藥提供可行的策略。我們的產品主要針對肺炎克雷伯菌引起的反复感染患者，結合抗生素和抗體-抗生素偶聯藥物的開發。
The feature of our product antibody- antibiotic conjugate drugs is that two different drugs can be bonded to the antibody to provide a feasible strategy for bacterial resistance.
The feature of our product antibody- antibiotic conjugate drugs is that two different drugs can be bonded to the antibody to provide a feasible strategy for bacterial resistance.